These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31430188)

  • 1. Proton therapy for locally advanced non-small cell lung cancer.
    Gjyshi O; Liao Z
    Br J Radiol; 2020 Mar; 93(1107):20190378. PubMed ID: 31430188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.
    Chang JY; Jabbour SK; De Ruysscher D; Schild SE; Simone CB; Rengan R; Feigenberg S; Khan AJ; Choi NC; Bradley JD; Zhu XR; Lomax AJ; Hoppe BS;
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):505-516. PubMed ID: 27084663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Therapy in Non-small Cell Lung Cancer.
    Mesko S; Gomez D
    Curr Treat Options Oncol; 2018 Nov; 19(12):76. PubMed ID: 30483900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO
    Troost EGC; Wink KCJ; Roelofs E; Simone CB; Makocki S; Löck S; van Kollenburg P; Dechambre D; Minken AWH; van der Stoep J; Avery S; Jansen N; Solberg T; Bussink J; de Ruysscher D
    Br J Radiol; 2020 Mar; 93(1107):20190879. PubMed ID: 31804145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
    Prasanna PG; Rawojc K; Guha C; Buchsbaum JC; Miszczyk JU; Coleman CN
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1325-1340. PubMed ID: 33640423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care.
    Kamran SC; Light JO; Efstathiou JA
    Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):509-521. PubMed ID: 30967625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer.
    Chang JY; Liu HH; Komaki R
    Curr Oncol Rep; 2005 Jul; 7(4):255-9. PubMed ID: 15946583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Quest for Evidence for Proton Therapy: Model-Based Approach and Precision Medicine.
    Widder J; van der Schaaf A; Lambin P; Marijnen CAM; Pignol JP; Rasch CR; Slotman BJ; Verheij M; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):30-36. PubMed ID: 26684410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial Dose Patterns Associated With Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Photon Therapy With Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Palma G; Monti S; Xu T; Scifoni E; Yang P; Hahn SM; Durante M; Mohan R; Liao Z; Cella L
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1124-1132. PubMed ID: 30822531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photons, protons or carbon ions for stage I non-small cell lung cancer - Results of the multicentric ROCOCO in silico study.
    Wink KCJ; Roelofs E; Simone CB; Dechambre D; Santiago A; van der Stoep J; Dries W; Smits J; Avery S; Ammazzalorso F; Jansen N; Jelen U; Solberg T; de Ruysscher D; Troost EGC
    Radiother Oncol; 2018 Jul; 128(1):139-146. PubMed ID: 29545019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sparing Cardiac Substructures With Optimized Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-small Cell Lung Cancer.
    Ferris MJ; Martin KS; Switchenko JM; Kayode OA; Wolf J; Dang Q; Press RH; Curran WJ; Higgins KA
    Pract Radiat Oncol; 2019; 9(5):e473-e481. PubMed ID: 31077884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.
    Roelofs E; Engelsman M; Rasch C; Persoon L; Qamhiyeh S; de Ruysscher D; Verhaegen F; Pijls-Johannesma M; Lambin P;
    J Thorac Oncol; 2012 Jan; 7(1):165-76. PubMed ID: 22071782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma.
    Haefner MF; Verma V; Bougatf N; Mielke T; Tonndorf-Martini E; König L; Rwigema JM; Simone CB; Uhlmann L; Eichhorn F; Winter H; Grosch H; Haberer T; Herfarth K; Debus J; Rieken S
    Acta Oncol; 2018 Dec; 57(12):1713-1720. PubMed ID: 30264630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
    Fleckenstein J; Kremp K; Kremp S; Palm J; Rübe C
    Strahlenther Onkol; 2016 Feb; 192(2):75-82. PubMed ID: 26438071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung cancer.
    McDermott RL; Armstrong JG; Thirion P; Dunne M; Finn M; Small C; Byrne M; O'Shea C; O'Sullivan L; Shannon A; Kelly E; Hacking DJ
    Radiother Oncol; 2018 May; 127(2):253-258. PubMed ID: 29548561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
    Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; de Jong ME; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1216-24. PubMed ID: 20732761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.